Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received a consensus rating of “Buy” from the nine research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $15.64.

CCRN has been the subject of a number of recent analyst reports. Zacks Investment Research raised Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a report on Monday. Benchmark Co. reduced their target price on Cross Country Healthcare from $18.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 3rd. UBS AG reissued a “buy” rating and issued a $15.00 target price (down previously from $16.50) on shares of Cross Country Healthcare in a report on Wednesday, June 14th. BMO Capital Markets reduced their target price on Cross Country Healthcare from $18.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, May 5th. Finally, BidaskClub downgraded Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th.

Cross Country Healthcare (NASDAQ:CCRN) traded up 2.51% during trading on Tuesday, hitting $12.68. 251,743 shares of the stock traded hands. Cross Country Healthcare has a 12 month low of $10.54 and a 12 month high of $16.38. The stock’s market cap is $452.05 million. The firm’s 50-day moving average is $12.38 and its 200-day moving average is $13.45.

Cross Country Healthcare (NASDAQ:CCRN) last released its earnings results on Wednesday, August 2nd. The business services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.07. Cross Country Healthcare had a return on equity of 12.78% and a net margin of 1.06%. The company had revenue of $209.31 million during the quarter, compared to the consensus estimate of $209.92 million. During the same quarter last year, the company earned $0.16 earnings per share. Cross Country Healthcare’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, analysts forecast that Cross Country Healthcare will post $0.61 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/08/cross-country-healthcare-inc-nasdaqccrn-receives-average-rating-of-buy-from-analysts.html.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Louisiana State Employees Retirement System boosted its position in shares of Cross Country Healthcare by 0.8% in the first quarter. Louisiana State Employees Retirement System now owns 13,400 shares of the business services provider’s stock worth $192,000 after buying an additional 100 shares in the last quarter. Prudential Financial Inc. boosted its position in shares of Cross Country Healthcare by 28.7% in the first quarter. Prudential Financial Inc. now owns 91,529 shares of the business services provider’s stock worth $1,314,000 after buying an additional 20,384 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of Cross Country Healthcare by 3.1% in the first quarter. Acadian Asset Management LLC now owns 246,415 shares of the business services provider’s stock worth $3,538,000 after buying an additional 7,318 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of Cross Country Healthcare by 244.1% in the fourth quarter. Renaissance Technologies LLC now owns 158,018 shares of the business services provider’s stock worth $2,467,000 after buying an additional 112,101 shares in the last quarter. Finally, Royce & Associates LP boosted its position in shares of Cross Country Healthcare by 98.1% in the first quarter. Royce & Associates LP now owns 579,686 shares of the business services provider’s stock worth $8,324,000 after buying an additional 287,123 shares in the last quarter. Institutional investors and hedge funds own 90.00% of the company’s stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.